AR099137A2 - FORMULATION FOR DIRECT COMPRESSION AND PROCESS - Google Patents
FORMULATION FOR DIRECT COMPRESSION AND PROCESSInfo
- Publication number
- AR099137A2 AR099137A2 ARP150100149A ARP150100149A AR099137A2 AR 099137 A2 AR099137 A2 AR 099137A2 AR P150100149 A ARP150100149 A AR P150100149A AR P150100149 A ARP150100149 A AR P150100149A AR 099137 A2 AR099137 A2 AR 099137A2
- Authority
- AR
- Argentina
- Prior art keywords
- percent
- dry weight
- pharmaceutically acceptable
- weight
- weight basis
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Una composición farmacéutica, la cual comprende: (a) del 5 al 60 por ciento en peso, sobre una base de peso seco, de un inhibidor de dipeptidil-peptidasa IV en forma libre o en forma de sal de adición de ácido; (b) del 40 al 95 por ciento en peso, sobre una base de peso seco, de un diluyente farmacéuticamente aceptable; (c) del 0 al 20 por ciento en peso, sobre una base de peso seco, de un desintegrante farmacéuticamente aceptable; (d) del 0.1 al 10 por ciento en peso, sobre una base de peso seco, de un lubricante farmacéuticamente aceptable. Reivindicación 14: Una composición de acuerdo con cualquiera de las reivindicaciones 1 a 12, en donde el inhibidor de dipeptidil-peptidasa IV es 1-[3-hidroxi-adamant-1-il-amino)-acetil]-pirrolidin-2(S)-carbonitrilo.Claim 1: A pharmaceutical composition, which comprises: (a) 5 to 60 percent by weight, on a dry weight basis, of a dipeptidyl peptidase IV inhibitor in free form or in the form of acid addition salt ; (b) from 40 to 95 percent by weight, on a dry weight basis, of a pharmaceutically acceptable diluent; (c) from 0 to 20 percent by weight, on a dry weight basis, of a pharmaceutically acceptable disintegrant; (d) 0.1 to 10 percent by weight, on a dry weight basis, of a pharmaceutically acceptable lubricant. Claim 14: A composition according to any one of claims 1 to 12, wherein the dipeptidyl peptidase IV inhibitor is 1- [3-hydroxy-adamant-1-yl-amino) -acetyl] -pyrrolidin-2 (S ) -carbonitrile.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53770604P | 2004-01-20 | 2004-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR099137A2 true AR099137A2 (en) | 2016-06-29 |
Family
ID=39962907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150100149A AR099137A2 (en) | 2004-01-20 | 2015-01-20 | FORMULATION FOR DIRECT COMPRESSION AND PROCESS |
Country Status (4)
| Country | Link |
|---|---|
| CN (2) | CN101618216B (en) |
| AR (1) | AR099137A2 (en) |
| TN (1) | TNSN06223A1 (en) |
| ZA (1) | ZA200605513B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104856970B (en) * | 2015-06-23 | 2017-08-25 | 张磊 | A kind of vildagliptin tablet for treating type II diabetes |
| CN105233300B (en) * | 2015-11-05 | 2019-10-25 | 北京泰德制药股份有限公司 | A kind of stable vildagliptin composition and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3131402A1 (en) * | 1981-08-07 | 1983-02-24 | Kilian & Co GmbH, 5000 Köln | METHOD AND TABLET PRESS FOR THE SUCCESSFUL PRODUCTION OF A VARIETY OF TABLETS OF THE SAME WEIGHT |
| DE19823831A1 (en) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | New pharmaceutical use of isoleucyl thiazolidide and its salts |
| FR2822826B1 (en) * | 2001-03-28 | 2003-05-09 | Servier Lab | NOVEL ALPHA-AMINO ACID SULPHONYL DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| FR2824825B1 (en) * | 2001-05-15 | 2005-05-06 | Servier Lab | NOVEL ALPHA-AMINOACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| JP2005519052A (en) * | 2002-01-11 | 2005-06-30 | アスファルマ リミテッド | Pravastatin pharmaceutical preparation and method of use thereof |
| JP2003327532A (en) * | 2002-05-10 | 2003-11-19 | Takeda Chem Ind Ltd | Peptidase inhibitor |
-
2005
- 2005-01-17 CN CN200910164779XA patent/CN101618216B/en active Active
- 2005-01-17 CN CNA2005800056665A patent/CN101262851A/en active Pending
-
2006
- 2006-07-04 ZA ZA200605513A patent/ZA200605513B/en unknown
- 2006-07-19 TN TNP2006000223A patent/TNSN06223A1/en unknown
-
2015
- 2015-01-20 AR ARP150100149A patent/AR099137A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101262851A (en) | 2008-09-10 |
| CN101618216A (en) | 2010-01-06 |
| TNSN06223A1 (en) | 2007-12-03 |
| CN101618216B (en) | 2012-01-04 |
| ZA200605513B (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20100200A7 (en) | A PHARMACEUTICAL COMPOSITION THAT INCLUDES N- (3,4-DIFLUORO-2-4-IODOFENILAMINO) -6-METOXIFENIL) -L- (2,3-DIHIDROXIPROPIL) CICLOPROPANO-L-SULFONAMIDE, USEFUL FOR THE TREATMENT AND PREVENTION OF CANNER OF INFLAMMATORY DISEASES | |
| AR049000A1 (en) | FORMULATION FOR DIRECT COMPRESSION AND PROCESS FOR THE PREPARATION OF A DIRECTLY COMPRESSED TABLET | |
| CO5640076A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDED BY AN IBAT INHIBITOR FOR THE TREATMENT OR PROFILAXIS OF THE CONSTIPATION | |
| AR056291A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TROMBOSIS TREATMENT | |
| GT200500309A (en) | DERIVATIVES OF SULFONILBENCILIMIDAZOL | |
| CL2008003298A1 (en) | Solid oral dosage form comprising a) a dual-acting compound in concentration between 4 and 90%, b) a pharmaceutically acceptable excipient; Preparation process; use in the treatment of cardiovascular and / or kidney diseases. | |
| CR7432A (en) | ACTIVE REPLACED AMIDAS OF THE CANABINOID RECEIVER-1 | |
| BRPI0616694B8 (en) | process for preparing pharmaceutical tablet with 80 and 96% by weight based on dry weight of vildagliptin and metformin or their pharmaceutically acceptable salts | |
| MA28432B1 (en) | ANTAGONISTS OF THE CHEMOKINE RECEPTOR | |
| PA8669801A1 (en) | ASSOCIATION BETWEEN RAILWAY AND AN ARTEMISININE DERIVATIVE FOR TREATMENT OF PALUDISM | |
| AR041089A1 (en) | PROCEDURE AND PHARMACEUTICAL COMPOSITIONS TO TREAT ATEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED AFFECTIONS | |
| AR062980A1 (en) | PHARMACEUTICAL COMPOSITIONS OF PIRIMIDIL-AMINO-BENZAMIDA COMPOUNDS | |
| AR067184A1 (en) | USE OF 6- (3-CHLORO-2-FLUORBENCIL) -1 - [(2S) -1-HIDROXI-3-METILBUTAN-2-IL] -7-METOXI-4-OXO-1,4-DIHYDROCHINOLINE-3- CARBOXILICO. PHARMACEUTICAL COMPOSITION | |
| PA8586501A1 (en) | AVAILABLE TABLETS THAT INCLUDE A BENZOIC ACID DERIVATIVE | |
| ECSP088379A (en) | AVAILABLE TABLETS THAT INCLUDE DEFERASIROX | |
| EA201201496A1 (en) | A method of inhibiting HIV integrase, METHOD FOR IMPROVED PHARMACOKINETICS 6- (3-chloro-2-fluorobenzyl) -1 - [(2S) -1-Hydroxy-3-methylbutan-2-yl] -7-methoxy-4-oxo-1 4-DIHYDROCHINOLIN-3-CARBONIC ACID (OPTIONS), SET, PHARMACEUTICAL COMPOSITION (OPTIONS) AND ANTIRETROVIRAL AGENT (OPTIONS) | |
| PE20040104A1 (en) | PHARMACEUTICAL COMPOSITION THAT HAS A UNIFORM DISTRIBUTION AND POTENCY OF DRUG | |
| PE20110431A1 (en) | DABIGATRAN ETEXYLATE OR A SALT OF THE SAME | |
| WO2007005990A3 (en) | Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke | |
| DOP2012000050A (en) | NEW COMPOSITIONS OF 1- [2- (2,4-DIMETIL-PHENYL SULFANIL) -PENYL] PIPERAZINA | |
| EA201101231A1 (en) | METHODS TO PREVENT OR REDUCE THE RISK OF MORTALITY | |
| AR057885A1 (en) | ACID 1- (1- (2- ETOXIETIL) - 1- ETIL-7- (4- METHYLPIRIDIN -2- ILAMINO) - 1H PIRAZOLO (4,3-D) PIRIMIDIN -5- IL) PIPERIDINE -4- CARBOXYL AND SALTS OF THE SAME. PHARMACEUTICAL COMPOSITIONS. | |
| AR048589A1 (en) | PIRROLIDINE DERIVATIVES -3,4-DICARBOXAMIDA | |
| AR099137A2 (en) | FORMULATION FOR DIRECT COMPRESSION AND PROCESS | |
| AR040441A1 (en) | TIOL COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND INTERMEDIATE COMPOSITE OF UTILITY IN THIS PROCEDURE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |